Comparison of oral versus intravenous vitamin D receptor activator in reducing infection-related mortality in hemodialysis patients: the Q-Cohort Study

Conclusions
Treatment with intravenous VDRA more effectively reduces the incidence of mortality from infection than oral VDRA in hemodialysis patients.

Source: Nephrology Dialysis Transplantation - June 21, 2016 Category: Urology & Nephrology Authors: Tanaka, S., Ninomiya, T., Taniguchi, M., Fujisaki, K., Tokumoto, M., Hirakata, H., Ooboshi, H., Kitazono, T., Tsuruya, K. Tags: Intra- and extracorporeal treatments of kidney failure Source Type: research